Tech Center 1600 • Art Units: 1611
This examiner grants 28% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17798531 | OMECAMTIV MECARBIL TABLET | Final Rejection | Amgen Inc. |
| 17503762 | MULTI-PHASE ORAL COMPOSITION FOR DELIVERING ORAL CARE ACTIVE AGENTS | Non-Final OA | The Procter & Gamble Company |
| 17268129 | CORE BODY TEMPERATURE REDUCING AGENT, FOOD PRODUCT, AND SLEEP IMPROVING AGENT | Final Rejection | JAPAN TOBACCO INC. |
| 17840276 | METHODS TO ENHANCE BIOAVAVAILABILITY OF ORGANIC SMALL MOLECULES AND DEPOSITED FILMS MADE THEREFROM | Final Rejection | THE REGENTS OF THE UNIVERSITY OF MICHIGAN |
| 17479614 | CHEWABLE GEL PRODUCTS FOR ACTIVE PHARMACEUTICAL INGREDIENTS | Final Rejection | Bayer HealthCare LLC |
| 15301281 | CONTRACEPTIVE AND RELATED DEVICE | Non-Final OA | POLY-MED, INC. |
| 18265324 | PERSONAL CARE COMPOSITION | Final Rejection | Conopco, Inc., d/b/a UNILEVER |
| 17713803 | FABRIC COMPOSITIONS COMPRISING ATTACHED ZEOLITE AND/OR A ZEOLITE/PECTIN COMPLEX | Non-Final OA | Virginia Commonwealth University |
| 18709906 | HEIGHT-ADJUSTABLE SPRINKLER | Non-Final OA | BTGIN CO., LTD. |
| 18283379 | COSMETIC | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 17854688 | DISRUPTED CARTILAGE PRODUCTS | Final Rejection | OSIRIS THERAPEUTICS, INC. |
| 18144365 | ANHYDROUS HYDROCOLLOID MATRIX COMPRISING HOMOGENEOUSLY DISTRIBUTED ENCAPSULATED THERAPEUTIC AGENTS | Non-Final OA | Peace Out, LLC |
| 18339310 | THERAPEUTIC USE OF CHARDONNAY SEED PRODUCTS | Non-Final OA | The United States of America, as represented by the Secretary of Agriculture |
| 18398021 | SUSPENSION COMPOSITIONS OF MULTI-TARGET INHIBITORS | Final Rejection | AIVIVA BIOPHARMA, INC. |
| 16585630 | METHODS AND COMPOSITIONS FOR ENHANCING HEALTH | Non-Final OA | Ojai Energetics PBC |
| 18239557 | Dermal Patch for Transdermal Administration of Ghrelin Pathway Blocker | Non-Final OA | Resarcion LLC |
| 18024788 | PREPARATIONS CONTAINING MITRAGYNE EXTRACT OR ITS ISOLATED ALKALOIDS AND CANNABIS EXTRACT OR ITS ISOLATED CANNABINOIDS, AND COSMETIC AND/OR PHARMACEUTICAL USE THEREOF | Non-Final OA | Herba Invest Europe DOO |
| 16968710 | HAEMOSTATIC MATERIAL | Final Rejection | MEDTRADE PRODUCTS LIMITED |
| 17912278 | CANNABINOID MEDICAL CARRIER | Non-Final OA | New York Medical College |
| 18015952 | FORMULATION PRODUCT | Non-Final OA | Nutriigen Ltd. |
| 17809174 | CORONA DISCHARGE TREATED TRANSDERMAL DELIVERY SYSTEM | Final Rejection | Corium, LLC |
| 18046551 | Drug Eluting Foams and the Production Thereof | Non-Final OA | Polyganics IP B.V. |
| 17529591 | Drug Eluting Foams and the Production Thereof | Final Rejection | Polyganics IP B.V. |
| 16382652 | Drug Eluting Foams and the Production Thereof | Final Rejection | Polyganics IP B.V. |
| 17964270 | TRANSDERMAL DEVICE COMPRISING IBUPROFEN PRODRUG MOLECULES | Non-Final OA | Remedy Diagnostics LLC |
| 17907373 | METHOD FOR OBTAINING A BOTANICAL EXTRACT | Final Rejection | EUROMED, S.A. |
| 17694312 | TOPICAL DRUG DELIVERY DEVICES AND METHODS OF USE | Final Rejection | MJS Solutions, LLC |
| 17401598 | TRANSDERMAL PHARMACEUTICAL FORMULATIONS OF NABILONE ALONE AND IN COMBINATION WITH CANNABINOIDS | Non-Final OA | Pike Therapeutics Inc. |
| 17331119 | INTRAVAGINAL RING DEVICES | Final Rejection | DARÉ BIOSCIENCE, INC. |
| 16678466 | INHALABLE HEMODYNAMIC AGENTS AND METHODS OF USING THE SAME | Final Rejection | TRUIST BANK, AS ADMINISTRATIVE AGENT |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy